Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Blood (2024) 144 (Supplement 1): 6718.

https://doi.org/10.1182/blood-2024-209513

Published: 2024

Journal Articles

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Blood (2023) 142 (Supplement 1): 5179.

https://doi.org/10.1182/blood-2023-185122

Published: 2023

Journal Articles

Data-Driven Harmonization of 2022 Who and ICC Classifications of Myelodysplastic Syndromes/Neoplasms (MDS): A Study By the International Consortium for MDS (icMDS)

Luca Lanino, Somedeb Ball, Jan Philipp Bewersdorf, Monia Marchetti, Giulia Maggioni, Erica Travaglino, Najla H Al Ali, Pierre Fenaux, Uwe Platzbecker, Valeria Santini, Maria Diez-Campelo, Avani M Singh, Akriti Gupta Jain, Luis E. Aguirre, Sara M. Tinsley-Vance, Zaker I. Schwabkey, Onyee Chan, Zhuoer Xie, Andrew M. Brunner, Andrew T. Kuykendall, John M. Bennett, Rena Buckstein, Rafael Bejar, Hetty E. Carraway, Amy E. DeZern, Elizabeth A. Griffiths, Stephanie Halene, Robert Hasserjian, Jeffrey Lancet, Alan F. List, Sanam Loghavi, Olatoyosi Odenike, Eric Padron, Mrinal M. Patnaik, Gail J. Roboz, Maximilian Stahl, Mikkael A. Sekeres, David Peter Steensma, Michael R. Savona, Justin Taylor, Mina Xu, Kendra Sweet, David A Sallman, Stephen D. Nimer, Christopher S. Hourigan, Andrew H. Wei, Elisabetta Sauta, Saverio D'Amico, Gianluca Asti, Gastone Castellani, Uma M. Borate, Guillermo Sanz, Fabio Efficace, Steven D. Gore, Tae Kon Kim, Naval Daver, Guillermo Garcia-Manero, María Rozman, Alberto Orfao, Sa A. Wang, M. Kathy Foucar, Ulrich Germing, Torsten Haferlach, Phillip Scheinberg, Yasushi Miyazaki, Marcelo Iastrebner, Austin Kulasekararaj, Thomas Cluzeau, Shahram Kordasti, Arjan A. van de Loosdrecht, Lionel Ades, Amer M. Zeidan, Rami S. Komrokji, Matteo Giovanni Della Porta

Blood (2023) 142 (Supplement 1): 998.

https://doi.org/10.1182/blood-2023-186580

Published: 2023

Journal Articles

Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes

Blood (2023) 141 (17): 2047–2061.

https://doi.org/10.1182/blood.2022018604

Published: 2023

Includes: Supplemental data

Journal Articles

Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Marcelo Iastrebner, Renee Leonor Crisp, Roberto Ovilla, Andres Gomez-De Leon, Adriana Karola Puente, Fernando Barroso Duarte, Elvira DRP Velloso, Breno Gusmao, Ana Varela, Matilde Boada, Sofia Grille

Blood (2022) 140 (Supplement 1): 12329–12330.

https://doi.org/10.1182/blood-2022-163174

Published: 2022

Journal Articles

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Sofia Grille, Elvira DRP Velloso, Matilde Boada, Elia Apodaca Chavez, Andres Gomez-De Leon, Anna Cecilia Rodríguez-Zuñiga, Emmanuel Martínez Moreno, Fernando Perez-Jacobo, Graciela Alfonso, Juan Carlos Serrano, Natalia Tejeira, Lilián Díaz, Valentina Olivares, Laura Kornblihtt, Sergio Schusterschitz, Marcelo Iastrebner

Blood (2022) 140 (Supplement 1): 4096–4097.

https://doi.org/10.1182/blood-2022-168893

Published: 2022

Journal Articles

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Roberto Ovilla, MD, Renee Leonor Crisp, PhD, Pamela E Baez-Islas, MD, Jorge A Arbelbide, MD, Sofia Grille, MD PhD, Lilián Díaz, MD, Henry Idrobo, MD Professor, Alicia Enrico, MD, Maria J Mela Osorio, MD, Isolda I. Fernandez, MD, Luciana C Ferrari, MD, Nidia Zapata, MD, Adrian A Ceballos-Lopez, Veronica Mena, MD, Ana L Romero, MD, Juan Carlos Serrano, MD, Gabriela Vidal-Senmache, MD, Fernando Barroso Duarte, MD, Edit N Pintos, MD, Mariana Rosenhain, MD, Laura Kornblihtt, MD, Natalia Tejeira, MD, Breno Gusmao, MD, Maria Elena Del Rocio Buenaño, MD, Marcos Di Stefano, MD, Matilde Boada, MD, Alberto Gimenez Conca, MD, Maria Perusini, MD, Hernan Dick, MD, Santiago Cranco, MD, Maria Lucia Fuente, Alicia Beatriz Navickas, MD, Maria M Moirano, MD, Natalia Oliveira, MD, Jacqueline Gonzalez, MD, Mariana Bandín, MD, Noelia Villaverde, MD, Alejandro Suero, MD, Juan Felipe Lasso, MD, Nora Carrara, MD, Xochitl Cota, MD, Carolina Lazzarino, MD, Maria Leticia Rapan, MD, Marcelo Iastrebner, MD, Latin-American MDS Group (GLAM), MDS and Acute Leukemia Sub-Commission Group Argentinian Society of Hematology

Blood (2019) 134 (Supplement_1): 5096.

https://doi.org/10.1182/blood-2019-125311

Published: 2019

Journal Articles

Real World Data on Obstetric (OC) and Maternal Complications (MC) Occurring in a Cohort of Patients with Ph Negative Myeloproliferative Neoplasms (MPN): Argentinian Multicentric Study

Blood (2019) 134 (Supplement_1): 1669.

https://doi.org/10.1182/blood-2019-131778

Published: 2019

Journal Articles

Cytogenetic Features and Prognosis of 943 South American Patients with De Novo Myelodysplastic Syndromes: A Multicenter Study

Carolina Belli, PhD, Ronald Feitosa Pinheiro, MD PhD, Silvia M. M. Magalhaes, MD, Jacqueline Gonzalez, MD, Marcelo Iastrebner, MD, Maria Virginia Prates, MD, Silvia Benasayag, Yesica Bestach, MSc, Juliana Cordeiro, Marcela Cavalcante de Andrade Silva, Roberta da Silva Tanizawa, Raquel M Bengió, MD, Cecilia Lang, Elsa Nucifora, MD, Irene B Larripa, PhD, Elvira RP Velloso, MD PhD

Blood (2014) 124 (21): 5618.

https://doi.org/10.1182/blood.V124.21.5618.5618

Published: 2014

Journal Articles

Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial,

M. Judith Peterschmitt, MD, Ravi S Kamath, MD, Elena Lukina, PhD, MD, Nora Watman, MD, Marta Dragosky, M.D., Marcelo Iastrebner, M.D., Gregory M Pastores, Elsa Avila Arreguin, M.D., Mici Phillips, M.D., Hanna Rosenbaum, MD, Elena Sysoeva, Rasha Aguzzi, Leorah H Ross, Ana Cristina Puga, M.D., Daniel I Rosenthal, M.D.

Blood (2011) 118 (21): 3216.

https://doi.org/10.1182/blood.V118.21.3216.3216

Published: 2011

Journal Articles

Overall Survival by Prognosis Score in High-Risk Myelodysplastic Syndromes (MDS) Patients Receiving Decitabine Treatment: Results From Clinical Experience

Marcelo Iastrebner, MD, Jun Ho Jang, MD, Kihyun Kim, MD, Chul W. Jung, MD, PhD, Elsa Nucifora, MD, Federico Sackmann, Sergio Orlando, MD, Graciela Klein, MD, Juan Garcia, MD, Carolina Belli, PhD, Luis Quiroga, MD, Fernando Santini, MD, Haydee i Bernard, MD, Lino Salvatierra, MD, Gustavo Taborda, MD, Raquel Bengió, MD

Blood (2011) 118 (21): 5024.

https://doi.org/10.1182/blood.V118.21.5024.5024

Published: 2011

Journal Articles

Eliglustat, An Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 3 Years

M. Judith Peterschmitt, MD, Elena Lukina, PhD, MD, Nora Watman, MD, Marta Dragosky, M.D., Marcelo Iastrebner, M.D., Gregory Pastores, M.D., Elsa Avila Arreguin, M.D., Mici Phillips, M.D., Hanna Rosenbaum, MD, Elena Sysoeva, Rasha Aguzzi, Leorah H Ross, Ana Cristina Puga, M.D.

Blood (2011) 118 (21): 1104.

https://doi.org/10.1182/blood.V118.21.1104.1104

Published: 2011

Journal Articles

Eliglustat Tartrate, a Novel Investigational Oral Substrate Reduction Therapy for Gaucher Disease Type 1: Updated Phase 2 Results.

Elena Lukina, Judith Peterschmitt, Nora Watman, Marta Dragosky, Marcelo Iastrebner, Gregory Pastores, Elsa Avila Arreguin, Hanna Rosenbaum, Mici Phillips, Mathilde Kaper, Arshadul Haque, Ana Cristina Puga

Blood (2010) 116 (21): 3791.

https://doi.org/10.1182/blood.V116.21.3791.3791

Published: 2010

Journal Articles

Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study

Elena Lukina, Nora Watman, Elsa Avila Arreguin, Marta Dragosky, Marcelo Iastrebner, Hanna Rosenbaum, Mici Phillips, Gregory M. Pastores, Ravi S. Kamath, Daniel I. Rosenthal, Mathilde Kaper, Tejdip Singh, Ana Cristina Puga, M. Judith Peterschmitt

Blood (2010) 116 (20): 4095–4098.

https://doi.org/10.1182/blood-2010-06-293902

Published: 2010

Journal Articles

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1

Elena Lukina, Nora Watman, Elsa Avila Arreguin, Maryam Banikazemi, Marta Dragosky, Marcelo Iastrebner, Hanna Rosenbaum, Mici Phillips, Gregory M. Pastores, Daniel I. Rosenthal, Mathilde Kaper, Tejdip Singh, Ana Cristina Puga, Peter L. Bonate, M. Judith Peterschmitt

Blood (2010) 116 (6): 893–899.

https://doi.org/10.1182/blood-2010-03-273151

Published: 2010

Journal Articles

Genz-112638 for Gaucher Disease Type 1: Phase 2 Clinical Trial Results After 18 Months of Treatment.

Judith Peterschmitt, MD, Elena Lukina, PhD, MD, Nora Patricia Watman, MD, Elsa Avila Arreguin, MD, Maryam Banikazemi, MD, Gregory Pastores, MD, Marcelo Iastrebner, MD, Marta Dragosky, MD, Hanna Rosenbaum, MD, Mici Phillips, MD, Mathilde Kaper, Tejdip Singh, MD, Ana Cristina Puga, MD, PhD

Blood (2009) 114 (22): 1349.

https://doi.org/10.1182/blood.V114.22.1349.1349

Published: 2009

Journal Articles

Effectiveness of Decitabine in Chronic Myelomonocytic Leukemia Patients. International Cooperative Multi-Center Study.

Marcelo Iastrebner, MD, Jun Ho Jang, Isolda Fernandez, Kihyun Kim, M.D., Guy Garay, Dong Hwan (Dennis) Kim, Silvia Saba, Chul Won Jung, Fernando Santini, MD, Haydee i Bernard, MD, Lino Salvatierra, MD, Jorge Korin, MD, Gustavo Taborda, Ricardo Antonio Giuliani, MD, Gabriela Flores, Alejandro Flores, MD

Blood (2009) 114 (22): 3809.

https://doi.org/10.1182/blood.V114.22.3809.3809

Published: 2009

Journal Articles

Applicability of a New Prognostic Scoring System in Myelodysplastic Syndromes. MDS Study Group of Hematology.

Gabriela Flores, Maria Isabel Santos, MD, Graciela Alfonso, MD, Maria Cabrejo, Maria Virginia Prates, Marcelo Iastrebner, MD, Dorotea Beatriz Fantl, MD, Jorge Arbelbide, Reinaldo Campestri, MD, Diana Penchasky, MD, Paula Cardenas, MD, Federico Sackmann, Juan Garcia, MD, Elsa Nucifora, MD, Ana Basquiera, Astrid Pavlovsky, Miguel Arturo Pavlovsky, Isolda Fernandez, Susana Viñuales, MD

Blood (2009) 114 (22): 4838.

https://doi.org/10.1182/blood.V114.22.4838.4838

Published: 2009

Journal Articles

Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study.

Marcelo Iastrebner, MD, Jun Ho Jang, Elsa Nucifora, MD, Kihyun Kim, M.D., Federico Sackmann, Dong Hwan (Dennis) Kim, Sergio Orlando, Chul Won Jung, Ana Basquiera, MD, Raquel Bengio, Luis Quiroga, MD, Graciela Klein, MD, Juan Garcia, MD, Jorge Arbelbide, Astrid Pavlovsky, Maria Virginia Prates

Blood (2009) 114 (22): 3804.

https://doi.org/10.1182/blood.V114.22.3804.3804

Published: 2009

Journal Articles

Decitabine Activity in Chronic Myelomonocytic Leukemia Patients

Marcelo Iastrebner, MD, Guy Garay, MD, Graciela Klein, MD, Alejandro Flores, MD, Elsa Nucifora, MD, Graciela Alfonso, MD, Moro Diego, MD, Ana Basquiera, MD, Moira Lluesma Goalons, MD, Diana Saracut, MD, Miguel Gonzalez, MD, Luis Quiroga, MD, Luis Palmer, MD, Fernando Santini, MD

Blood (2008) 112 (11): 5081.

https://doi.org/10.1182/blood.V112.11.5081.5081

Published: 2008

NARROW

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Data-Driven Harmonization of 2022 Who and ICC Classifications of Myelodysplastic Syndromes/Neoplasms (MDS): A Study By the International Consortium for MDS (icMDS)

Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes

Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Real World Data on Obstetric (OC) and Maternal Complications (MC) Occurring in a Cohort of Patients with Ph Negative Myeloproliferative Neoplasms (MPN): Argentinian Multicentric Study

Cytogenetic Features and Prognosis of 943 South American Patients with De Novo Myelodysplastic Syndromes: A Multicenter Study

Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial,

Overall Survival by Prognosis Score in High-Risk Myelodysplastic Syndromes (MDS) Patients Receiving Decitabine Treatment: Results From Clinical Experience

Eliglustat, An Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 3 Years

Eliglustat Tartrate, a Novel Investigational Oral Substrate Reduction Therapy for Gaucher Disease Type 1: Updated Phase 2 Results.

Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1

Genz-112638 for Gaucher Disease Type 1: Phase 2 Clinical Trial Results After 18 Months of Treatment.

Effectiveness of Decitabine in Chronic Myelomonocytic Leukemia Patients. International Cooperative Multi-Center Study.

Applicability of a New Prognostic Scoring System in Myelodysplastic Syndromes. MDS Study Group of Hematology.

Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study.

Decitabine Activity in Chronic Myelomonocytic Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only